Study ID | Number | Study Title | Institute | Species | Analysis |
---|---|---|---|---|---|
ST000004 | 63 metabolites | Lipidomics studies on NIDDK / NIST human plasma samples | LIPID MAPS | Homo sapiens | MS |
ST000005 | 20 metabolites | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | LIPID MAPS | Mus musculus | MS |
ST000046 | 1 metabolites | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Mayo Clinic | Homo sapiens | MS |
ST000047 | 3 metabolites | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Mayo Clinic | Homo sapiens | MS |
ST000076 | 20 metabolites | A549 Cell Study | University of Kentucky | Homo sapiens | MS |
ST000077 | 7 metabolites | Metabolite changes associated with methionine stress sensitivity of cancer (CSH QTOF MS analysis) | University of California, Davis | Homo sapiens | MS |
ST000081 | 1 metabolites | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of subcutaneous and visceral adipose tissue samples | University of California, Davis | Homo sapiens | MS |
ST000082 | 7 metabolites | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of serum samples | University of California, Davis | Homo sapiens | MS |
ST000089 | 7 metabolites | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis | University of California, Davis | Homo sapiens | MS |
ST000110 | 28 metabolites | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) | University of Kentucky | Homo sapiens | MS |
ST000114 | 68 metabolites | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | University of Kentucky | Homo sapiens | MS |
ST000142 | 1 metabolites | H1299 13C-labeled Cell Study | University of Kentucky | Homo sapiens | MS |
ST000148 | 54 metabolites | A549 13C-labeled Cell Study | University of Kentucky | Homo sapiens | MS |
ST000241 | 7 metabolites | Cyclobutene- and cyclobutane-functionalized fatty acids as novel biochemical probes of structure and function in HepG2 cells | University of Nebraska-Lincoln | Homo sapiens | MS |
ST000242 | 2 metabolites | Whole unconditioned medium (Defined culture media, M199),Whole M1 medium,Whole M2 medium | Mayo Clinic | Homo sapiens | MS |
ST000269 | 2 metabolites | Diacylglyceride and Ceramide analysis in TFD mice | University of Florida | Mus musculus | MS |
ST000310 | 10 metabolites | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | University of Florida | Mus musculus | MS |
ST000320 | 1 metabolites | Single treatment gene impact on Arabidopsis metabolites | University of California, Davis | Arabidopsis thaliana | MS |
ST000321 | 1 metabolites | Effects of LGG on current drinkers gut metabolism | University of California, Davis | Mus musculus | MS |
ST000322 | 1 metabolites | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 1:Plasma) | University of California, Davis | Bos taurus | MS |
ST000323 | 1 metabolites | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 2:Uterine flush) | University of California, Davis | Bos taurus | MS |
ST000324 | 2 metabolites | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 3:Ovaries) | University of California, Davis | Bos taurus | MS |
ST000328 | 8 metabolites | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | University of California, Davis | Canis lupus familiaris | MS |
ST000329 | 8 metabolites | Minimal change disease and focal segmental sclerosis in urine | University of California, Davis | Homo sapiens | MS |
ST000330 | 7 metabolites | Effects of Zinc on GI tract metabolites (Part 1: Esophagus) | University of California, Davis | Mus musculus | MS |
ST000331 | 6 metabolites | Effects of Zinc on GI tract metabolites (Part 2: Prostate) | University of California, Davis | Mus musculus | MS |
ST000332 | 2 metabolites | Effects of Giardia intestinalis on mice GI tract | University of California, Davis | Mus musculus | MS |
ST000339 | 6 metabolites | Metabolites in peritoneal macrophages and bone marrow derived macrophages | University of California, Davis | Mus musculus | MS |
ST000342 | 5 metabolites | Renal metabolic pathways indicating ischemic or inflammatory changes | University of California, Davis | Homo sapiens | MS |
ST000344 | 6 metabolites | Effects of dietary supplement on hamster metabolism | University of California, Davis | Cricetinae | MS |
ST000346 | 1 metabolites | Metabolites detected from human bronchoalveolar lavage | University of California, Davis | Homo sapiens | MS |
ST000354 | 7 metabolites | Metabolite comparison of mouse gastric tissue and glands | University of California, Davis | Mus musculus | MS |
ST000362 | 24 metabolites | Associations between 69 Sphingolipids and Emphysema, Chronic Bronchitis, Exacerbations, and FEV1/FVC | National Jewish Health, Colorado | Homo sapiens | MS |
ST000422 | 1 metabolites | Type 1 Diabetes good glycemic control and controls samples | Mayo Clinic | Homo sapiens | MS |
ST000423 | 6 metabolites | Differences in mycoplasma growth due to different mediums | University of California, Davis | Mus musculus | MS |
ST000445 | 3 metabolites | Follicular fluid lipidomics reveals lipid alterations by LH addition during IVF cycles | Universidade Federal de Sao Paulo | Homo sapiens | MS |
ST000450 | 11 metabolites | Metabolic features of chronic fatigue syndrome | University of California, San Diego | Homo sapiens | MS |
ST000465 | 12 metabolites | Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response | University of California, San Diego | Homo sapiens | MS |
ST000546 | 1 metabolites | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Monash University | Plasmodium falciparum | MS |
ST000549 | 3 metabolites | Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors | Mayo Clinic | Mus musculus | MS |
ST000608 | 4 metabolites | Comparing identified and statistically significant lipids and polar metabolites in 15-year old serum and dried blood spot samples for longitudinal studies | Pacific Northwest National Laboratory | Homo sapiens | MS |
ST000617 | 7 metabolites | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | University of California, San Diego | Homo sapiens | MS |
ST000797 | 3 metabolites | Targeted Galactosyl Sphingolipids Concentrations of Myelin to Enhance Recovery of Function after SCI | Mayo Clinic | Mus musculus | MS |
ST000852 | 3 metabolites | Targeting Myelin Galactosyl Sphingolipids of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCI | Mayo Clinic | Mus musculus | MS |
ST000859 | 3 metabolites | Targeted Galactosyl Sphingolipid Concentration in Kallikrein 6 Mice after SCI | Mayo Clinic | Mus musculus | MS |
ST000899 | 3 metabolites | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Vanderbilt University Medical Center | Homo sapiens | MS |
ST000915 | 38 metabolites | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 1:Liver | LIPID MAPS | Homo sapiens | MS |
ST000916 | 38 metabolites | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | LIPID MAPS | Homo sapiens | MS |
ST000917 | 38 metabolites | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | LIPID MAPS | Homo sapiens | MS |
ST000963 | 45 metabolites | Lipidomics of inflammation-induced optic nerve regeneration | University of Miami | Rattus norvegicus | MS |
ST000983 | 4 metabolites | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | University of California, Davis | Homo sapiens | MS |
ST000984 | 4 metabolites | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | University of California, Davis | Homo sapiens | MS |
ST000985 | 4 metabolites | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) | University of California, Davis | Homo sapiens | MS |
ST000986 | 4 metabolites | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | University of California, Davis | Homo sapiens | MS |
ST000987 | 4 metabolites | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) | University of California, Davis | Homo sapiens | MS |
ST000988 | 4 metabolites | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | University of California, Davis | Homo sapiens | MS |
ST000989 | 4 metabolites | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | University of California, Davis | Homo sapiens | MS |
ST000990 | 4 metabolites | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | University of California, Davis | Homo sapiens | MS |
ST000991 | 4 metabolites | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | University of California, Davis | Homo sapiens | MS |
ST001019 | 25 metabolites | Lipidomic profiling of heart and plasma of mice following swim training versus pressure overload | Baker Heart and Diabetes Institute | Mus musculus | MS |
ST001059 | 26 metabolites | Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-II) | South East Center for Integrated Metabolomics | Oreochromis mossambicus | MS |
ST001063 | 28 metabolites | Lipidomics analysis for aged mice epididymal adipose tissue (part-I) | Takeda Pharmaceutical Company Limited | Mus musculus | MS |
ST001065 | 36 metabolites | Lipidomics analysis for aged mice brain cortex (part-II) | Takeda Pharmaceutical Company Limited | Mus musculus | MS |
ST001066 | 26 metabolites | Lipidomics analysis for aged mice liver (part-III) | Takeda Pharmaceutical Company Limited | Mus musculus | MS |
ST001067 | 29 metabolites | Lipidomics analysis for aged mice femoral muscle (part - IV) | Takeda Pharmaceutical Company Limited | Mus musculus | MS |
ST001073 | 42 metabolites | Lipid profiling of Wnt3a-induced optic nerve regeneration | University of Miami | Mus musculus | MS |
ST001102 | 4 metabolites | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-II) | NOAA NWFSC | Metacarcinus magister | MS |
ST001105 | 9 metabolites | Retinal ganglion cells lipid profiling | University of Miami | Mus musculus | MS |
ST001115 | 30 metabolites | Growth cone-enriched lipidome of embryonic to early postnatal mouse brain | University of Miami | Mus musculus | MS |
ST001140 | 26 metabolites | Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure | National University of Singapore, University of Zurich | Canis lupus familiaris | MS |
ST001151 | 3 metabolites | 4-day dietary effect of fast food vs Mediterranean diet to HDL lipidome | University of California, Davis | Homo sapiens | MS |
ST001154 | 6 metabolites | A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium | University of California, Davis | Mus musculus | MS |
ST001157 | 9 metabolites | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Johns Hopkins University School of Medicine | Mus musculus | MS |
ST001158 | 1 metabolites | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Johns Hopkins University School of Medicine | Mus musculus | MS |
ST001165 | 2 metabolites | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-III) | NOAA NWFSC | Metacarcinus magister | MS |
ST001204 | 1 metabolites | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001210 | 18 metabolites | Comprehensive UHPLC-MS/MS lipidomics profiling to study effects of betulin on keratinocytes | Eberhard Karls University of Tübingen | Homo sapiens | MS |
ST001211 | 7 metabolites | Metabolomic Markers of Methotrexate Response, In Vitro | University Of Kansas | Homo sapiens | MS |
ST001212 | 10 metabolites | Fish-oil supplementation in pregnancy, child metabolomics and asthma risk | University of Copenhagen | Homo sapiens | MS |
ST001251 | 2 metabolites | The effects of a training program encompassing cold exposure, breathing exercises, and meditation on plasma metabomics during experimental human endotoxemia | Radboud University Medical Centre | Homo sapiens | MS |
ST001253 | 4 metabolites | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Indiana University School of Medicine | Mus musculus | MS |
ST001267 | 25 metabolites | Mass spectrometry-based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism | University of Helsinki | Homo sapiens | MS |
ST001269 | 24 metabolites | Exosomal lipids for classifying early and late stage non-small cell lung cancer | University of Kentucky | Homo sapiens | MS |
ST001272 | 62 metabolites | Growth cone memebrane and growth cone particulate lipidomics | University of Miami | Mus musculus | MS |
ST001273 | 26 metabolites | Lipidomics Dataset of Sonication-Induced Traumatic Optic Neuropathy in Mice | University of Miami | Mus musculus | MS |
ST001274 | 1 metabolites | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Monash University | Trypanosoma brucei brucei | MS |
ST001275 | 2 metabolites | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) | Monash University | Trypanosoma brucei brucei | MS |
ST001276 | 2 metabolites | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Monash University | Trypanosoma brucei brucei | MS |
ST001286 | 20 metabolites | Lipid composition of isolated lipid droplets from the functional bovine corpus luteum | University of Nebraska Medical Center | Bos taurus | MS |
ST001288 | 16 metabolites | Subcellular organelle lipidomics in TLR-4-activated macrophages | LIPID MAPS | Mus musculus | MS |
ST001289 | 16 metabolites | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | LIPID MAPS | Mus musculus | MS |
ST001304 | 2 metabolites | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Monash University | Toxoplasma gondii | MS |
ST001327 | 7 metabolites | Mitochondrial Lipid Profiles in Traumatic Optic Neuropathy | University of Miami | Mus musculus | MS |
ST001336 | 1 metabolites | Effect of high-fat diet and bile acid treatment on serum and tissue lipidomes in mice | QIMR Berghofer Medical Research Institute | Mus musculus | MS |
ST001341 | 18 metabolites | C56BL6 BMDM stimulated with different TLRs W/O acetylated LDL (part-II) | University of California, Los Angeles | Mus musculus | MS |
ST001342 | 16 metabolites | Timecourse of C56BL6 BMDM stimulated with different TLRs (part-I) | University of California, Los Angeles | Mus musculus | MS |
ST001343 | 12 metabolites | C56BL6 WT or TRIFKO BMDM stimulated with different TLRs (part-III) | University of California, Los Angeles | Mus musculus | MS |
ST001344 | 15 metabolites | C56BL6 WT or MyD88KO BMDM stimulated with different TLRs (part-IV) | University of California, Los Angeles | Mus musculus | MS |
ST001345 | 13 metabolites | C56BL6 WT or IFNARKO BMDM stimulated with different TLRs (part-V) | University of California, Los Angeles | Mus musculus | MS |
ST001349 | 10 metabolites | Multiparous and Primiparous Simmental Dairy Cows | Institute of Animal Nutrition and Functional Plant Compounds | Bos taurus | MS |
Return to search page